"If you ve possibly been exposed to the coronavirus (COVID-19) and are experiencing symptoms, we recommend that your first contact with a health care provider be through telemedicine. Houston Methodist Virtual Urgent Care is available 24/7- no appointment necessary. Or, if you re planning an in-person visit, please call ahead to inform your healthcare provider."

During the past decade, Houston Methodist Neurological Institute conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 21 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Methodist Neurological Institute" #1 sponsor was "Massachusetts General Hospital" with 4 trials, followed by "GE Healthcare" with 2 trials sponsored, "Grifols Therapeutics LLC" with 2 trials sponsored, "Knopp Biosciences" with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Neurological Institute" #1 collaborator was "Muscular Dystrophy Association" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "ALS Association" with 3 trials as a collaborator and "Biogen" with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist Neurological Institute" are "Amyotrophic Lateral Sclerosis" (11 trials), "Stroke" (5 trials), "Parkinson Disease" (4 trials), "ALS" (3 trials) and "Glioblastoma Multiforme" (3 trials). Many other conditions were trialed in "Houston Methodist Neurological Institute" in a lesser frequency.

Most popular intervention types in "Houston Methodist Neurological Institute" are "Drug" (39 trials), "Other" (8 trials), "Biological" (5 trials), "Device" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "placebo" (4 trials), "ADV/HSV-tk (gene therapy)" (2 trials), "Dexpramipexole" (2 trials) and "IGIV-C" (2 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist Neurological Institute" are 52 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Houston Methodist Neurological Institute". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Houston Methodist Neurological Institute, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist Neurological Institute, 7 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".